Publications by authors named "E T Tanda"

Claim this Profile
H
High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Michele Guida, Benedetta Apollonio, Luca Romano, Francesco Spagnolo, Pietro Quaglino, Enrica Tanda

J Transl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related osteitis mimicking femoral head osteonecrosis during dual checkpoint blockade: a case report.
Enrica Teresa Tanda, Agostina Lagodin D'Amato, Giovanni Rossi, Maria Maddalena Latocca, Andrea Boutros

Front Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for resectable NSCLC: neoadjuvant/perioperative followed by surgery over surgery followed by adjuvant. Systematic review and meta-analysis with subgroup analyses.
G Rossi, L Barcellini, M Tagliamento, E T Tanda, M C Garassino

ESMO Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Determinants of Response to PARP Inhibition in Germline Mutant Melanoma.
Eleonora Allavena, Michela Croce, Bruna Dalmasso, Cecilia Profumo, Valentina Rigo, Enrica Teresa Tanda

Int J Mol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab.
I Vanni, M Croce, L Pastorino, E Allavena, F Barbero, E T Tanda

J Transl Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis